View Older Stories View More Recent Stories

Jan 30, 2024 08:00AM Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparati
Nov 13, 2023 04:05PM Motus GI Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Oct 24, 2023 08:06AM Motus GI Holdings (MOTS) Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon
Oct 24, 2023 08:00AM Motus GI Receives FDA Clearance to Commercialize Pure-Vu EVS Gastro and Gen 4 Colon
Sep 26, 2023 08:04AM Motus GI Holdings (MOTS) Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon
Sep 26, 2023 08:00AM Motus GI Submits Special 510(k) to FDA for Pure-Vu EVS Gen 4 Gastro and Colon
Sep 14, 2023 04:06PM Motus GI (MOTS) Amends Royalty Agreement
Sep 14, 2023 04:05PM Motus GI Amends Royalty Agreement
Sep 6, 2023 05:02PM Motus GI Holdings (MOTS) Appoints Scott Durbin to its Board
Sep 6, 2023 05:00PM Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors
Aug 24, 2023 04:05PM Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 14, 2023 04:01PM Motus GI Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Aug 10, 2023 09:01AM Motus GI Holdings (MOTS) Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu EVS System
Aug 10, 2023 09:00AM Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System
Jul 20, 2023 08:02AM Motus GI Holdings (MOTS) Announces Purchase Agreement for the Pure-Vu System® from Banner Desert Medical Center
Jul 20, 2023 08:00AM Motus GI Announces Purchase Agreement for the Pure-Vu System® from Banner Desert Medical Center
Jun 14, 2023 08:00AM Motus GI Announces Pure-Vu Gen 4 Gastro and Colon System Featured at 9th IECED Live Endoscopy Course 2023 at the Pentax Learning Center
Jun 7, 2023 08:31AM Orchestra BioMed (MOTS) Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
Jun 7, 2023 08:30AM Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
Jun 5, 2023 04:43PM Motus GI Holdings (MOTS) Appoints Ravit Ram as CFO
Jun 5, 2023 04:42PM Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
May 17, 2023 08:30AM Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission
May 11, 2023 07:00AM Motus GI Announces DDW 2023 Clinical Study Presentation Showing Pure-Vu EVS Drove a 33% Hospital-Wide Improvement in Incomplete Bowel Prep Rate at Minneapolis VA Medical Center
May 10, 2023 04:05PM Motus GI Reports First Quarter 2023 Financial Results and Provides Corporate Update
Apr 13, 2023 04:06PM Motus GI Holdings (MOTS) Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones
Apr 13, 2023 04:05PM Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones
Mar 31, 2023 04:05PM Motus GI Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Jan 10, 2023 08:30AM Motus GI Announces Exploration of Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring Plan
Dec 21, 2022 08:00AM Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests
Nov 14, 2022 04:05PM Motus GI Reports Third Quarter 2022 Financial Results and Provides Business Update
Oct 31, 2022 04:05PM Motus GI to Release Third Quarter Results and Provide a Business Update on November 14
Oct 24, 2022 08:30AM Motus GI Announces Positive Clinical Data for Pure-Vu EVS in Three Poster Presentations at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting
Oct 6, 2022 09:02AM Motus GI Holdings (MOTS) Granted a U.S. Patent for Prepless Colonoscopy Methods Embodied by the Pure-Vu® System
Oct 6, 2022 09:00AM Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods Embodied by the Pure-Vu® System
Sep 29, 2022 09:04AM Motus GI Holdings (MOTS) Named a Sole Source Supplier with U.S. Department of Veteran Affairs
Sep 29, 2022 09:00AM Motus GI Named a Sole Source Supplier with U.S. Department of Veteran Affairs
Aug 11, 2022 04:05PM Motus GI Reports Second Quarter 2022 Financial Results and Provides Business Update
Aug 11, 2022 08:02AM Motus GI Holdings (MOTS) Regains Nasdaq Compliance
Aug 11, 2022 08:00AM Motus GI Regains Compliance with Nasdaq Minimum Bid Price Requirement
Jul 25, 2022 08:01AM Motus GI Holdings (MOTS) Announces 1:20 Reverse Stock Split
Jul 25, 2022 08:00AM Motus GI Announces 1-FOR-20 Reverse Stock Split
Jul 21, 2022 04:05PM Motus GI to Release Second Quarter Results and Provide a Business Update on August 11
May 24, 2022 04:05PM Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at Digestive Disease Week 2022
May 12, 2022 04:05PM Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update
May 2, 2022 08:00AM Motus GI Announces Upcoming Presentation of Topline Data from the EU Study of the Pure-Vu System at Digestive Disease Week 2022
Apr 28, 2022 08:00AM Motus GI to Release First Quarter Results and Provide a Business Update on May 12
Apr 21, 2022 08:00AM Motus GI Completes Enrollment in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients with a History of Poor Bowel Preparation
Mar 29, 2022 04:05PM Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Mar 15, 2022 04:05PM Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29
Mar 2, 2022 04:05PM Motus GI to Participate in Two Upcoming Investor Conferences in March 2022
View More Recent Stories View Older Stories